Evidence map›Paper›PMID 15799821›Full record

ArticleNeoplasia (New York, N.Y.)2005

Bone microenvironment modulates expression and activity of cathepsin B in prostate cancer.

Izabela Podgorski, Bruce E Linebaugh, Mansoureh Sameni, Christopher Jedeszko, Sunita Bhagat, Michael L Cher, Bonnie F Sloane

Open access · goldAbstract read
In one paragraph

Article in Neoplasia (New York, N.Y.), 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 76 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Engineering small-molecule and protein drugs for targeting bone tumors.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Biomarkers and Bone Imaging Dynamics Associated with Clinical Outcomes of Oral Cabozantinib Therapy in Metastatic Castrate-Resistant Prostate Cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2019
    Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. The histone deacetylase inhibitor cambinol prevents acidic pHBiochemistry and biophysics reports · 2015
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Izabela PodgorskiDepartment of Pharmacology, Wayne State University School of Medicine, Detroit, MI 48201, USA. ipodgors@med.wayne.edu
Bruce E Linebaugh
Mansoureh Sameni
Christopher Jedeszko
Sunita Bhagat
Michael L Cher
Bonnie F Sloane
Wayne State University · US

Funding

Tumor Biology and Microenvironment (Program 1)P30CA022453 · NCI · WAYNE STATE UNIVERSITY · PI PAUL M STEMMER · 1985 to 2026
$68.4M
RESEARCH CORE-- SIGNAL TRANSDUCTIONP30ES006639 · NIEHS · WAYNE STATE UNIVERSITY · PI DERESKI, MARY O · 1994 to 2008
$13.1M
NCI NIH HHS P30 CA022453NCI NIH HHS P30CA22453NIEHS NIH HHS P30 ES006639NIEHS NIH HHS P30ES06639
6 · The paper itself

Abstract

Prostate cancers metastasize to bone leading to osteolysis. Here we assessed proteolysis of DQ-collagen I (a bone matrix protein) and, for comparison, DQ-collagen IV, by living human prostate carcinoma cells in vitro. Both collagens were degraded, and this degradation was reduced by inhibitors of matrix metallo, serine, and cysteine proteases. Because secretion of the cysteine protease cathepsin B is increased in human breast fibroblasts grown on collagen I gels, we analyzed cathepsin B levels and secretion in prostate cells grown on collagen I gels. Levels and secretion were increased only in DU145 cells--cells that expressed the highest baseline levels of cathepsin B. Secretion of cathepsin B was also elevated in DU145 cells grown in vitro on human bone fragments. We further investigated the effect of the bone microenvironment on cathepsin B expression and activity in vivo in a SCID-human model of prostate bone metastasis. High levels of cathepsin B protein and activity were found in DU145, PC3, and LNCaP bone tumors, although the PC3 and LNCaP cells had exhibited low cathepsin B expression in vitro. Our results suggest that tumor-stromal interactions in the context of the bone microenvironment can modulate the expression of the cysteine protease cathepsin B.

Indexed as

AnimalsBlotting, NorthernBone and BonesBone NeoplasmsCathepsin BCell Line, TumorCell SurvivalCoculture TechniquesCollagenCollagen Type ICollagen Type IVCulture Media, ConditionedCysteine EndopeptidasesElectrophoresis, Polyacrylamide GelFemurFibroblastsCathepsin BCollagenCollagen Type ICollagen Type IVCulture Media, ConditionedCysteine EndopeptidasesPlasticsRNA, Messenger

Identifiers

PMID15799821
PMCPMC1501133
OpenAlexW2024001437

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.